joimax® Announces Executive Appointments Among Record-Breaking Sales for 2022

KARLSRUHE, Germany – (BUSINESS WIRE) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, has appointed Mr. Maximilian Ries and Mr. Anthony Troncale to new executive positions, effective January 1. The announcement comes among record-breaking sales across Europe, Asia, and the United States in 2022.

Maximilian Ries

Ries took on the newly created role of Executive Vice President, Business Development and Operations at joimax®. In this position, based in Germany, he will be responsible for scaling global operations to ensure joimax® continues its exponential growth. Formerly the General Manager, for the past six of his 13-year tenure with joimax®, Ries built out the United States and Latin American markets.

Tony Troncale

Troncale was promoted to General Manager; he was formerly Vice President of Marketing and Business Development at joimax® Inc. Over the past two years, Troncale, in addition to increasing his responsibilities, successfully capitalized on the significant interest in endoscopic techniques to expand US sales operations. He joined joimax® in 2021 bringing 20-years of experience in the spinal device industry where he served in sales and marketing leadership roles at Stryker, K2M, and Synthes Spine. Contributing to the global organization’s continuous strong sales growth was the launch of a new surgical access system, “Tessys® Trans SAP” and the global expansion of the ESPINEA® Education Academy.

Wolfgang Ries

“I am extremely pleased with our 2022 global performance and the significant interest in endoscopic spine surgery,” stated joimax® Founder and CEO Wolfgang Ries. “With Max and Tony in their new roles, our market-leading endoscopic spine technologies, and our anticipated launch of two more new surgical access systems later in 2023, we are well positioned for another very successful year.”

joimax® Experiences Major Growth, Launches TESSYS® TransSAP Endoscopic Surgical System

KARLSRUHE, Germany – (BUSINESS WIRE) – joimax® is continuing its year-over-year double digit growth. Over the past 9 months, joimax® has grown more than 25% globally and in the United States alone, more than 35%. Among this major spurt, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery is launching a new endoscopic surgical system, TESSYS® TransSAP.

“This allows for more extensive foraminal decompression and provides an optimal basis for transforaminal endoscopic fusion”

The company attributes strong growth to their popular workshop and educational program, which is now offered worldwide under the ESPINEA® training academy. To keep momentum, joimax® is releasing the TESSYS® TransSAP — the fourth addition to the TESSYS® family encompassing the standard TESSYS® Std, TESSYS® XT featuring longer reach instruments, and TESSYS® Thx, the optimized version for the thoracic spine.

The system is based on the proven TESSYS® method introduced in 2004. Since then, the technology has been enhanced and can be used for more complex indications, widening the spectrum of disease and vertebral level applications.

joimax® faculty surgeon masters, Dr. Christof Hofstetter and Dr. Ralf Wagner, demonstrate TESSYS® and iLESSYS® to an at capacity crowd during NASS 2022 in Chicago. (Photo: Business Wire)

“The TransSAP method follows an adopted access path to the spine, directly targeting the Superior Articulating Process,” says Dr. Christoph Hofstetter, associate professor in the Department of Neurological Surgery at the University of Washington. “This allows for more extensive foraminal decompression and provides an optimal basis for transforaminal endoscopic fusion,” adds Dr. Ralf Wagner, a longstanding joimax® ESPINEA® Faculty orthopedic surgeon based in Frankfurt.

In addition, joimax® provides a series of implants for fusion indications, such as the percutaneous pedicle screw system, Percusys® Plus, and a family of 3D-printed titanium cages within the EndoLIF® program. The EndoLIF® suite of products consists of the static implants O/On-Cage, Delta-Cage and DoubleWedge-Cage. “There are plans to add a new fully-expandable cage, as well as a navigated solution for endoscopic disc preparation and implant positioning to provide a full endoscopic assisted fusion platform,” says Wolfgang Ries, CEO and founder of joimax®.

All joimax® implants can be safely inserted using the “Over-the-Wire” technique for precise implantation, making them ideal for endoscopically-assisted fusion procedures established and protected by joimax®.

These new products have been exhibited at the following trade shows: SMISS in Las Vegas, CNS in San Francisco, and NASS in Chicago, and will be featured at EUROSPINE in Milan and at the German Spine Congress, DWG, in Berlin later this year.

joimax®announces major spike in attendance at its ESPINEA® workshops, reports record revenues

Karlsruhe (GER) — German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce a major spike in attendance at its Endoscopic Spine Academy (ESPINEA®) workshops, which contributes to sustainable growth after another year of record revenues in 2021.

The growing interest can be attributed to increased coverage in literature and publications as cited on PubMed®. Moreover, the joimax®-initiated workshop program, now under the umbrella of ESPINEA®, offers optimal training for a variety of applications and procedures, making it attractive to a broader audience. 

joimax® established ESPINEA® three years ago. In Fall 2020, the Endoscopic Spine Academy was accredited by the Royal College of Surgeons Edinburgh (RCSEd). It is one of only four Accreditation Centers that meet its strict rigorous internal quality assurance processes. Together, with its growing team of faculty, joimax® developed the complete six-step curriculum to bridge the learning curve for spine surgeons. The curriculum, which was approved by the RCSEd, is developed as an educational program from beginners to masters alike.

J.N. Alastair Gibson DSc MD FRCSEd, a RCSEd and ESPINEA® Advisory Board Member sums it up: “The ESPINEA® mission is to serve endoscopic spine surgeons by providing a growing global network for lifelong learning to best benefit the patient. Our vision is to be the world’s leading interdisciplinary community in endoscopic spine surgery.”

In addition to holding ESPINEA® courses at the joimax®-owned premises in Karlsruhe (Germany) and Irvine (USA), they are also held at ORSI Academy (Belgium) and at other prestigious universities, such as Paracelsus Medical University Salzburg (Austria). Recently, ESPINEA® was rolled out in Thailand. Prior to the July PASMISS Meeting, the courses will be launched in Singapore for the APAC region, and following the October SMISS Meeting, launched widely in the U.S.

“Given the ongoing development of endoscopic spine surgery with more and more technological options, the benefits for the patients, along with the substantial publication, I am convinced that endoscopic spine surgery is now the gold standard,” states Iprenburg Spine Clinic Founder and ESPINEA® Advisory Board Member Dr. Menno Iprenburg.

With the ESPINEA® courses, surgeons can train on different procedures using the joimax® TESSYS®, iLESSYS®, CESSYS®, MultiZYTE®, EndoLIF®, Percusys® based on the latest NAVENTO® tower. Most of the courses are conducted in a hybrid mode — online and on-site presentations and lectures combined with in-person hands-on training using models, simulators and anatomical specimens.

ESPINEA® was established as an open education platform for other players in the field of spinal surgery as well. Therefore, further supporters have already joined and new entrants are welcomed.

joimax® announces 510(k) clearance for its Endovapor® 2 Multi Radio Frequency System with its first presentation at the Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) 2017, in Los Angeles

Irvine, CA – April 26, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor® 2 Multi Radio Frequency System.

The patented device generates electrical power for monopolar and bipolar cutting and coagulation of tissue structures in surgical operations. The joimax® Endovapor® 2 is an all-in-one generator with specially integrated programs for spinal surgery with interdisciplinary application. The device is equipped with two monopolar and two bipolar sockets and an easy and intuitive touchpad technology. With arc control for safe application and easy neutral electrode monitoring, it combines a variety of different electro-surgical modes and effects.

“After receiving the FDA clearance for the joimax® Vaporflex® and Legato® electrosurgical probes in early  November 2016, this is another milestone in strengthening the joimax® position as an expert in endoscopic minimally invasive spine surgery,” states Wolfgang Ries, Founder and CEO of joimax®.

During the AANS, joimax®  participated in the CME endoscopic cadaveric workshop with two stations and held a very successful US-expert meeting including topics such as training procedures, clinical Research and future technologies.